These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17311548)

  • 21. Angiogenesis in colorectal cancer: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Koukourakis MI
    Am J Clin Oncol; 2006 Aug; 29(4):408-17. PubMed ID: 16891872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Angiogenic Drugs, Vascular Toxicity and Thromboembolism in Solid Cancer.
    Riondino S; Del Monte G; Fratangeli F; Guadagni F; Roselli M; Ferroni P
    Cardiovasc Hematol Agents Med Chem; 2017; 15(1):3-16. PubMed ID: 28137223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for anti-angiogenic therapy in cancer.
    Wehland M; Bauer J; Magnusson NE; Infanger M; Grimm D
    Int J Mol Sci; 2013 Apr; 14(5):9338-64. PubMed ID: 23629668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor angiogenesis: new approaches to cancer therapy].
    Marmé D
    Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pharmacologic approaches to the prevention and treatment of ulcerative colitis.
    Deng X; Szabo S; Khomenko T; Tolstanova G; Paunovic B; French SW; Sandor Z
    Curr Pharm Des; 2013; 19(1):17-28. PubMed ID: 22950505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenic targets for potential disorders.
    Bhadada SV; Goyal BR; Patel MM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
    Klener P
    Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor angiogenesis].
    Bikfalvi A
    Bull Cancer; 2003 May; 90(5):449-58. PubMed ID: 12850768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor as a target for anticancer therapy.
    Ferrara N
    Oncologist; 2004; 9 Suppl 1():2-10. PubMed ID: 15178810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
    Furuya M; Yonemitsu Y; Aoki I
    Curr Pharm Des; 2009; 15(16):1854-67. PubMed ID: 19519428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor angiogenesis: a potential target in cancer control by phytochemicals.
    Singh RP; Agarwal R
    Curr Cancer Drug Targets; 2003 Jun; 3(3):205-17. PubMed ID: 12769689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
    Antoniades V; Sioga A; Dietrich EM; Meditskou S; Ekonomou L; Antoniades K
    Med Hypotheses; 2013 Dec; 81(6):1159-63. PubMed ID: 24210000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of tumor vascularization.
    Auguste P; Lemiere S; Larrieu-Lahargue F; Bikfalvi A
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):53-61. PubMed ID: 15780907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast tumour angiogenesis.
    Fox SB; Generali DG; Harris AL
    Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies.
    Rapisarda A; Melillo G
    Drug Resist Updat; 2009 Jun; 12(3):74-80. PubMed ID: 19394890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.